Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population

H Bower, M Björkholm, PW Dickman… - Journal of Clinical …, 2016 - ascopubs.org
Purpose A dramatic improvement in the survival of patients with chronic myeloid leukemia
(CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase inhibitor …
被引用次数：824 相关文章

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

H Bower, M Björkholm, PW Dickman… - Journal of Clinical …, 2016 - diva-portal.org
PURPOSE: A dramatic improvement in the survival of patients with chronic myeloid
leukemia (CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

H Bower, M Björkholm, PW Dickman… - Journal of Clinical …, 2016 - hero.epa.gov
PURPOSE: A dramatic improvement in the survival of patients with chronic myeloid
leukemia (CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

H Bower, M Björkholm, PW Dickman… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose A dramatic improvement in the survival of patients with chronic myeloid leukemia
(CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase inhibitor …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

H Bower, M Björkholm, PW Dickman, M Höglund… - 2016 - figshare.le.ac.uk
PURPOSE: A dramatic improvement in the survival of patients with chronic myeloid
leukemia (CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

H Bower, M Björkholm, PW Dickman… - Journal of Clinical …, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> A dramatic improvement in the
survival of patients with chronic myeloid leukemia (CML) occurred after the introduction of …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

H Bower, M Björkholm, PW Dickman… - Journal of Clinical …, 2016 - europepmc.org
Purpose A dramatic improvement in the survival of patients with chronic myeloid leukemia
(CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase inhibitor …

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

H Bower, M Björkholm, PW Dickman, M Höglund… - 2016 - figshare.le.ac.uk
PURPOSE: A dramatic improvement in the survival of patients with chronic myeloid
leukemia (CML) occurred after the introduction of imatinib mesylate, the first tyrosine kinase …